Analytics
The partnership will initially be used to distribute PathAI’s research-use-only algorithm focusing on immuno-oncology.
Also, US-based Pearl has received regulatory approvals to market its AI diagnostic tool for dental radiology in Australia and New Zealand.
A new AI screening tool has been trained to identify 14 of the most common retinal abnormalities.
Clinical research is set to verify the technology's effectiveness in estimating abnormal heart movements.
Analytics can improve social determinants of health, health equity and value-based care efforts, says Dr. Mike Dulin, chief medical officer at Gray Matter Analytics and a professor at UNC Charlotte.
Also, Australia insurer nib offers free access to newly launched digital health app Snug.
In the third quarter of 2021 alone, digital health companies scored $6.7 billion across 169 deals.
The latest approval marks DreaMed’s fourth clearance from the Food and Drug Administration.
The AI medical station can generate an automated diagnosis that remote care providers can access to confirm.
It has a dashboard that renders an analysis of patient visit trends and actionable intelligence for clinic upgrades.